Neoplasm coding is one of the most detail-intensive areas of ICD-10-CM. Every tumor, growth, mass, and cancer requires careful identification of both the anatomical site and the behavior of the neoplasm — and the two pieces of information together determine the correct code. This guide walks through neoplasm coding from the ground up so you can handle any tumor coding question on the CPC exam with confidence.
What Is a Neoplasm?
A neoplasm is any abnormal new growth of cells — whether cancerous or non-cancerous. The word comes from Greek meaning “new formation.” In ICD-10-CM, neoplasms are coded from Chapter 2 (C00–D49) and are always looked up using the Table of Neoplasms in the Alphabetic Index. Never try to code a neoplasm from the main index — always go directly to the Table of Neoplasms.
The Six Behavior Columns of the Neoplasm Table
Every entry in the Table of Neoplasms has six columns — one for each possible behavior. The pathology report or physician documentation determines which column you use:
Malignant Primary
The original site where cancer started. The tumor originated here.
Malignant Secondary
A metastatic site — cancer spread FROM a primary site TO here.
Ca In Situ
Cancer cells present but contained — has not invaded surrounding tissue yet.
Benign
Non-cancerous growth — does not invade or spread to other areas.
Uncertain Behavior
Pathologist cannot determine if benign or malignant — behavior unpredictable.
Unspecified
No pathology report available — behavior unknown or not documented.
Primary vs Secondary Malignancy — The Critical Distinction
The most commonly tested concept in neoplasm coding is the distinction between primary and secondary (metastatic) malignancy. Understanding this distinction is essential:
- Primary malignancy: The site where the cancer originally developed — where it started. Every cancer has one primary site.
- Secondary malignancy: A site to which cancer has spread via metastasis. A patient can have multiple secondary sites from a single primary cancer.
When a patient has cancer that has spread, you code both the primary site and the secondary site(s). The sequencing depends on which site is being treated at the current encounter.
Sequencing Rule — Primary and Secondary Malignancies
- If treatment is directed at the primary site → sequence the primary malignancy first
- If treatment is directed at a metastatic (secondary) site → sequence the secondary malignancy first, then the primary
- If treatment is directed at both equally → either may be sequenced first
C79.51 — Secondary malignant neoplasm of bone
Treatment focused on breast (primary) → breast cancer code sequenced first
C34.10 — Malignant neoplasm of upper lobe of bronchus or lung, unspecified side
Treatment focused on brain metastasis → secondary code sequenced first
Carcinoma In Situ — What It Means for Coding
Carcinoma in situ (CIS) means cancerous cells are present but are confined — they have not yet broken through the basement membrane into surrounding tissue. In situ carcinomas are coded from the third column of the Table of Neoplasms (D00–D09 range). They are serious but are considered a stage before invasive cancer and are coded distinctly from both benign tumors and invasive malignancies.
Admissions for Chemotherapy, Radiation, and Immunotherapy
When a patient is admitted specifically to receive chemotherapy, radiation therapy, or immunotherapy for cancer, the encounter code — not the cancer code — is sequenced first:
- Z51.11 — Encounter for antineoplastic chemotherapy (first-listed)
- Z51.12 — Encounter for antineoplastic immunotherapy (first-listed)
- Z51.0 — Encounter for antineoplastic radiation therapy (first-listed)
The neoplasm code is then listed as an additional diagnosis. This sequencing rule applies specifically when the patient’s sole reason for the encounter is to receive the therapy — not when the therapy is incidental to other treatment.
Coding a Personal History of Cancer
Once a cancer has been successfully treated and is no longer present, it is no longer coded as an active malignancy. Instead a personal history Z-code is used. This is an important distinction — continuing to code an active malignancy after successful treatment is overcoding.
- Z85.3 — Personal history of malignant neoplasm of breast
- Z85.118 — Personal history of other malignant neoplasm of bronchus and lung
- Z85.038 — Personal history of other malignant neoplasm of large intestine